Jpmorgan Chase & CO 2seventy Bio, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 514,767 shares of TSVT stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

514,767

Previous 532,432 3.32%

Holding current value

$1.54 Million

Previous $2.05 Million 18.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$3.85 - $5.05 $68,010 - $89,208	-17,665 Reduced 3.32%	514,767 $2.43 Million
Q2 2024 Aug 12, 2024	SELL	$3.6 - $5.79 $1.55 Million - $2.5 Million	-431,280 Reduced 44.75%	532,432 $2.05 Million
Q1 2024 May 10, 2024	SELL	$3.09 - $6.0 $155,439 - $301,824	-50,304 Reduced 4.96%	963,712 $5.16 Million
Q4 2023 Feb 12, 2024	SELL	$1.57 - $4.58 $530,426 - $1.55 Million	-337,851 Reduced 24.99%	1,014,016 $4.33 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $11.2 $564,110 - $2.01 Million	179,653 Added 15.33%	1,351,867 $5.3 Million
Q2 2023 Aug 11, 2023	SELL	$8.45 - $12.48 $3.48 Million - $5.14 Million	-411,467 Reduced 25.98%	1,172,214 $11.9 Million
Q1 2023 May 18, 2023	BUY	$9.21 - $14.98 $263,783 - $429,042	28,641 Added 1.84%	1,583,681 $16.2 Million
Q1 2023 May 11, 2023	BUY	$9.21 - $14.98 $5.27 Million - $8.58 Million	572,506 Added 58.27%	1,555,040 $15.9 Million
Q4 2022 Feb 13, 2023	BUY	$8.57 - $17.0 $499,562 - $990,964	58,292 Added 6.31%	982,534 $9.21 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $415,221 - $579,854	33,059 Added 3.71%	924,242 $13.4 Million
Q2 2022 Aug 11, 2022	BUY	$10.55 - $18.81 $4.31 Million - $7.68 Million	408,376 Added 84.58%	891,183 $11.8 Million
Q1 2022 May 11, 2022	SELL	$11.67 - $26.72 $256,704 - $587,759	-21,997 Reduced 4.36%	482,807 $8.24 Million
Q4 2021 Feb 10, 2022	BUY	$13.77 - $42.56 $6.95 Million - $21.5 Million	504,804 New	504,804 $12.9 Million

Others Institutions Holding TSVT

# of Institutions

126

Shares Held

45.6M

Call Options Held

122K

Put Options Held

19.8K

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $113M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO 2seventy Bio, Inc. Transaction History